If the patient has tried all approved treatments, is not eligible for a clinical trial or there is no clinical trial available and they suffer from a life threatening disease or condition* then they are eligible for leronlimab on a Right to Try basis.

* statute definition of "life threatening

Quote:

---

(1) Diseases or conditions where the likelihood of death is high unless the course of the disease is interrupted; and

(2) Diseases or conditions with potentially fatal outcomes, where the end point of clinical trial analysis is survival.

---

PTM1, with the numerous conditions listed the patient you describe would certainly be eligible.